Anti-inflammatory effect of quercetin and galangin in LPS-stimulated RAW264.7 macrophages and DNCB-induced atopic dermatitis animal models

International Journal of Molecular Medicine

Volumn 41, Issue 2, 2018, Pages 888-898

  Lee, Hae Nim ^a   Shin, Seong Ah ^a   Choo, Gang Sik ^a   Kim, Hyeong Jin ^a   Park, Young Seok ^a   Kim, Byeong Soo ^a   Kim, Sang Ki ^a   Cho, Sung Dae ^b   Nam, Jeong Seok ^c   Choi, Chang Sun ^d   Che, Jeong Hwan ^e,f   Park, Byung Kwon ^a   Jung, Ji Youn ^a  

^a Kongju National University   (South Korea)

^b Seoul National University   (South Korea)

^c Gwangju Institute of Science and Technology (GIST)   (South Korea)

^d Chung Ang University   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f Seoul National University Hospital   (South Korea)

Author keywords

Anti inflammation; Flavonol; Hydroxy group; Mitogen activated protein kinase; Nuclear factor B

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; GALANGIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; QUERCETIN; STRESS ACTIVATED PROTEIN KINASE; FLAVONOID; FLAVONOL DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAW 264.7 CELL LINE; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; INFLAMMATION; MAPK SIGNALING; PATHOLOGY;

ANIMALS; DERMATITIS, ATOPIC; DINITROCHLOROBENZENE; DISEASE MODELS, ANIMAL; FLAVONOIDS; FLAVONOLS; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; NITRIC OXIDE; QUERCETIN; RAW 264.7 CELLS;

EID: 85040467710     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2017.3296     Document Type: Article

References (44)

1. Aherne SA and O'Brien NM: Dietary favonols: chemistry, food content, and metabolism. Nutrition 18: 75-81, 2002.
2. Xiao J, Suzuki M, Jiang X, Chen X, Yamamoto K, Ren F and Xu M: Influence of B-ring hydroxylation on interactions of favonols with bovine serum albumin. J Agric Food Chem 56: 2350-2356, 2008.
3. Rogerio A P, Kanashiro A, Fontanari C, Da Silva EV, Lucisano-Valim YM, Soares EG and Faccioli LH: Anti-infa-mmatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Infamm Res 56: 402-408, 2007.
4. Lamson DW and Brignall MS: Antioxidants and cancer, part 3: quercetin. Altern Med Rev 5: 196-208, 2000.
5. Heo MY, Sohn SJ and Au WW: Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat Res 488: 135-150, 2001.
6. Galli SJ, Grimbaldeston M and Tsai M: Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8: 478-486, 2008.
7. Hofseth LJ and Ying L: Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochim Biophys Acta 1765: 74-84, 2006.
8. Leung DY: atopic dermatitis: the skin as a window into the patho-genesis of chronic allergic diseases. J Allergy Clin Immunol 96: 302-319, 1995.
9. Bieber T and Simon HU: Allergen-specific immunotherapy: current concepts and future directions. Allergy 66: 709-712, 2011.
10. Akdis CA, Akdis M, Trautmann A and Blaser K: immune regulation in atopic dermatitis. Curr Opin Immunol 12: 641-646, 2000.
11. Kanno S, Shouji A, Tomizawa A, Hiura T, Osanai Y, Ujibe M, Obara Y, Nakahata N and Ishikawa M: Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Life Sci 78: 673-681, 2006.
12. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H and Ikeda H: Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171-194, 2003.
13. Dhillon AS, Hagan S, Rath O and Kolch W: MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290, 2007.
14. Schaeffer HJ and Weber MJ: Mitogen-activated protein kinases: specifc messages from ubiquitous messengers. Mol Cell Biol 19: 2435-2444, 1999.
15. Longpré F, Garneau P, Christen Y and Ramassamy C: Protection by EGb 761 against β-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, And MAPKs pathways and inhibition of amyloid fbril formation. Free Radic Biol Med 41: 1781-1794, 2006.
16. Reber L, Vermeulen L, Haegeman G and Frossard N: Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in infammation. PLoS One 4: e4393, 2009.
17. Hiscott J, Kwon H and Génin P: Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest 107: 143-151, 2001.
18. Gloire G, Legrand-Poels S and Piette J: NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72: 1493-1505, 2006.
19. Kleemann R, Verschuren L, Morrison M, Zadelaar S, Van Erk MJ, Wielinga PY and Kooistra T: Anti-infammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 218: 44-52, 2011.
20. Jung YC, Kim ME, Yoon JH, Park PR, Youn HY, Lee HW and Lee JS: Anti-inflammatory effects of galangin on lipo-polysaccharide-activated macrophages via ERK and NF-κB pathway regulation. Immunopharmacol Immunotoxicol 36: 426-432, 2014.
21. Liu YN, Zha WJ, Ma Y, Chen FF, Zhu W, Ge A, Zeng XN and Huang M: Galangin attenuates airway remodelling by inhibiting TGF-β1-mediated ROS generation and MAPK/Akt phosphory-lation in asthma. Sci Rep 5: 11758, 2015.
22. Kang NJ, Han SC, Kang GJ, Koo DH, Koh YS, Hyun JW, Lee NH, Ko MH, Kang HK and Yoo ES: Diphlorethohydroxycarmalol inhibits interleukin-6 production by regulating NF-κB, STAT5 and SOCS1 in lipopolysaccharide-stimulated RAW264.7 cells. Mar Drugs 13: 2141-2157, 2015.
23. García-Lafuente A, Guillamón E, Villares A, Rostagno MA and Martínez JA: Flavonoids as anti-infammatory agents: implications in cancer and cardiovascular disease. Infamm Res 58: 537-552, 2009.
24. Karawajczyk A, Drgan V, Medic N, Oboh G, Passamonti S and Novic M: Properties of favonoids infuencing the binding to bili-translocase investigated by neural network modelling. Biochem Pharmacol 73: 308-320, 2007.
25. Lin WW and Karin M: A cytokine-mediated link between innate immunity, infammation, and cancer. J Clin Invest 117: 1175-1183, 2007.
26. Alderton WK, Cooper CE and Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615, 2001.
27. Bogdan C: Nitric oxide and the immune response. Nat Immunol 2: 907-916, 2001.
28. 2: invo-lvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. J Pharmacol Exp Ther 303: 1001-1006, 2002.
29. Lee JA, Song HY, Ju SM, Lee SJ, Kwon HJ, Eum WS, Jang SH, Choi SY and Park JS: Differential regulation of inducible nitric oxide synthase and cyclooxygenase-2 expression by superoxide dismutase in lipopolysaccharide stimulated R AW 264.7 cells. Exp Mol Med 41: 629-637, 2009.
30. Möller B and Villiger PM: Inhibition of IL-1, IL-6, And TNF-α in immune-mediated infammatory diseases. Springer Semin Immunopathol 27: 391-408, 2006.
31. Kwon HS, Park JH, Kim DH, Kim YH, Park JHY, Shin HK and Kim JK: Licochalcone A isolated from licorice suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice. J Mol Med (Berl) 86: 1287-1295, 2008.
32. Tak PP and Firestein GS: NF-kappaB: a key role in infammatory diseases. J Clin Invest 107: 7-11, 2001.
33. Shi Y, Tu Z, Tang D, Zhang H, Liu M, Wang K, Calderwood SK and Xiao X: The inhibition of LPS-induced production of infammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways. Shock 26: 277-284, 2006.
34. Oeckinghaus A, Hayden MS and Ghosh S: Crosstalk in NF-κB signaling pathways. Nat Immunol 12: 695-708, 2011.
35. Monasterio A, Urdaci MC, Pinchuk IV, López-Moratalla N and Martínez-Irujo JJ: Flavonoids induce apoptosis in human leukemia U937 cells through caspase-and caspase-calpain-dependent pathways. Nutr Cancer 50: 90-100, 2004.
36. Husain SR, Cillard J and Cillard P: Hydroxyl radical scavenging activity of favonoids. Phytochemistry 26: 2489-2491, 1987.
37. Heeba GH, Mahmoud ME and El Hanafy AA: Anti-infla-mmatory potential of curcumin and quercetin in rats: role of oxidative stress, heme oxygenase-1 and TNF-α. Toxicol Ind Health 30: 551-560, 2014.
38. Campbell JK, King JL, Harmston M, Lila MA and Erdman JW: Synergistic effects of flavonoids on cell proliferation in Hepa-1c1c7 and LNCaP cancer cell lines. J Food Sci 71: S358-S363, 2006.
39. Harasstani OA, Moin S, Tham CL, Liew CY, Ismail N, Rajajendram R, Harith HH, Zakaria ZA, Mohamad AS, Sulaiman MR, et al: Flavonoid combinations cause syner-gistic inhibition of proinfammatory mediator secretion from lipopolysaccharide-induced R AW 264.7 cells. Infamm Res 59: 711-721, 2010.
40. Turner PV, Brabb T, Pekow C and Vasbinder MA: Admin-istration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50: 600-613, 2011.
41. Leung DY: atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105: 860-876, 2000.
42. Arshad SH and Holgate S: The role of IgE in allergen-induced inflammation and the potential for intervention with a humanized monoclonal anti-IgE antibody. Clin Exp Allergy 31: 1344-1351, 2001.
43. Karki R, Jung MA, Kim KJ and Kim DW: Inhibitory effect of Nelumbo nucifera (Gaertn.) on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Evid Based Complement Alternat Med 2012: 153568, 2012.
44. Galli SJ and Tsai M: IgE and Mast cells in allergic disease. Nat Med 18: 693-704, 2012.